Northcoast Research Equities Analysts Lift Earnings Estimates for Smith & Nephew plc (SNN)

Smith & Nephew plc (NYSE:SNN) – Analysts at Northcoast Research lifted their FY2019 earnings estimates for shares of Smith & Nephew in a note issued to investors on Monday, May 13th. Northcoast Research analyst D. Keiser now anticipates that the medical equipment provider will post earnings per share of $2.06 for the year, up from their previous forecast of $2.04. Northcoast Research also issued estimates for Smith & Nephew’s Q4 2019 earnings at $1.14 EPS, Q2 2020 earnings at $1.00 EPS, Q4 2020 earnings at $1.21 EPS and FY2020 earnings at $2.21 EPS.

A number of other brokerages have also issued reports on SNN. Zacks Investment Research lowered shares of Smith & Nephew from a “hold” rating to a “sell” rating in a research report on Friday, February 1st. Canaccord Genuity reiterated a “buy” rating and issued a $10.00 price target on shares of Smith & Nephew in a report on Monday, April 8th. Finally, BNP Paribas lowered shares of Smith & Nephew from an “outperform” rating to a “neutral” rating in a report on Friday, February 8th. Six analysts have rated the stock with a hold rating and two have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $25.50.

Shares of NYSE SNN opened at $42.11 on Tuesday. Smith & Nephew has a 1 year low of $32.22 and a 1 year high of $42.76. The company has a market cap of $18.59 billion, a P/E ratio of 20.85, a PEG ratio of 3.11 and a beta of 0.42. The company has a current ratio of 2.10, a quick ratio of 1.15 and a debt-to-equity ratio of 0.27.

The business also recently declared a semiannual dividend, which was paid on Wednesday, May 8th. Shareholders of record on Friday, April 5th were issued a $0.44 dividend. This represents a dividend yield of 2.31%. The ex-dividend date was Thursday, April 4th. This is a positive change from Smith & Nephew’s previous semiannual dividend of $0.25. Smith & Nephew’s dividend payout ratio (DPR) is 42.57%.

Several institutional investors and hedge funds have recently made changes to their positions in the business. Citigroup Inc. boosted its holdings in shares of Smith & Nephew by 0.5% in the 4th quarter. Citigroup Inc. now owns 52,113 shares of the medical equipment provider’s stock valued at $1,947,000 after purchasing an additional 261 shares during the last quarter. Scotia Capital Inc. boosted its holdings in shares of Smith & Nephew by 5.3% in the 4th quarter. Scotia Capital Inc. now owns 6,639 shares of the medical equipment provider’s stock valued at $248,000 after purchasing an additional 336 shares during the last quarter. Wetherby Asset Management Inc. boosted its holdings in shares of Smith & Nephew by 2.1% in the 1st quarter. Wetherby Asset Management Inc. now owns 17,667 shares of the medical equipment provider’s stock valued at $709,000 after purchasing an additional 371 shares during the last quarter. Eagle Asset Management Inc. boosted its holdings in shares of Smith & Nephew by 2.6% in the 1st quarter. Eagle Asset Management Inc. now owns 16,024 shares of the medical equipment provider’s stock valued at $642,000 after purchasing an additional 401 shares during the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its holdings in shares of Smith & Nephew by 12.3% in the 1st quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 3,789 shares of the medical equipment provider’s stock valued at $152,000 after purchasing an additional 416 shares during the last quarter. Institutional investors own 9.09% of the company’s stock.

About Smith & Nephew

Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Featured Story: Outstanding Shares, Buying and Selling Stocks

Earnings History and Estimates for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.